Farringdon Capital’s Abbott ABT Stock Holding History

Farringdon Capital’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,315	Closed	-$443K	–	187
2026 Q1	$443K	Buy	+4,315	New	+$487K	0.1%	236
2025 Q4	–	Sell	-12,624	Closed	-$1.69M	–	417
2025 Q3	$1.69M	Buy	+12,624	New	+$1.66M	0.43%	56

Other funds holding ABT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Farringdon Capital's ABT Position: Q2 2026 in Review

Farringdon Capital sold out of Abbott (ABT) in Q2 2026, closing a stake of 4,315 shares — an estimated $443K sold.

Farringdon Capital first reported a position in ABT in Q3 2025 and held it in 2 quarters. The position peaked at $1.69M in Q3 2025. 2,968 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

Farringdon Capital reported no remaining Abbott position as of Q2 2026 after selling out during the quarter.
Farringdon Capital sold 4,315 Abbott shares in Q2 2026, an estimated $443K.
Farringdon Capital first reported a position in Abbott in Q3 2025 and held it in 2 quarters.
Farringdon Capital's Abbott position peaked at $1.69M in Q3 2025.
2,968 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Farringdon Capital's 13F filing for Q2 2026, filed 12 Aug 2026.